Navigation Links
Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting (OINV) in the US
Date:8/6/2014

xtremely pleased to enter into this exclusive US license agreement with Daiichi Sankyo," said Paul Bosse, Founder, President and Chief Executive Officer of Charleston Laboratories. "We look forward to applying our strong clinical and regulatory capabilities toward the goal of improving patient well-being.  This agreement highlights Charleston's tenacity and our long-term commitment to build a preeminent pain company that benefits patients and shareholders alike."

Wilson Sonsini Goodrich & Rosati acted as legal counsel to Charleston Laboratories.

About Charleston Laboratories, Inc.
Charleston Laboratories, Inc. is a privately held, specialty pharmaceutical company focused on the research and development of novel pain products to significantly reduce the burdensome side effects related to opioid analgesics and other products.  Charleston's product pipeline currently seeks to address unmet needs in Opioid-Induced Nausea and Vomiting (OINV), Postoperative Nausea and Vomiting (PONV), Chemotherapy-Induced Nausea and Vomiting (CINV), Radiation-Induced Nausea and Vomiting (RINV), and Migraine-Induced Nausea and Vomiting (MINV).  Charleston Laboratories intends to enter into discovery and commercialization alliances with partners motivated to introduce novel pain therapies that reduce the burdensome side effects related to opioid analgesics and other products. For more information, please visit www.charlestonlabs.com.

About Daiichi Sankyo
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, dyslipidemia and bacterial infections used by patients around the world, the Group has also launched treatments for thr
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration to Identify and Progress High Potential Therapeutics
2. Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use for Stroke Prevention in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
3. Daiichi Sankyos Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial
4. Daiichi Sankyos Once-Daily Edoxaban Shows Comparable Efficacy and Superiority for the Principal Safety Endpoint Compared to Warfarin in a Phase 3 Study for the Treatment of Symptomatic VTE and Prevention of its Recurrence
5. Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Councils Chairman of the Board
6. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
7. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
8. Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
9. CHPA Addresses Anti-Meth Policy at AP Lookahead Event Today in Charleston
10. CHPA to Address Anti-Meth Policy at AP Lookahead Event Today in Charleston
11. Strong Efficacy Data Prompt Charleston Laboratories to Halt Phase 3 Study of CL-108 in Patients with Moderate to Severe Acute Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 ... Summary GlobalData,s new ... provides key market data on the Brazil Gynecological ... of US dollars, volume (in units) and average ... Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and ...
(Date:9/17/2014)... Sept. 17, 2014  Levi & Korsinsky, LLP is ... possible claims of breaches of fiduciary duty by the ... get more information, click here: http://zlk.9nl.com/alexza-pharmaceuticals-alxa . There ... If you own common stock in Alexza Pharmaceuticals Inc. ... Eduard Korsinsky, Esq. either via email at ...
(Date:9/17/2014)... PITTSBURGH , Sept. 17, 2014 /PRNewswire-iReach/ ... a white paper discussing improvements in the ... anatomic structures for both normal and diseased ... real-time information, simplifies surgical procedures, lowers surgical ... robot-assisted surgical procedures. The ...
Breaking Medicine Technology:Brazil Gynecological Devices Market Outlook to 2020 2Brazil Gynecological Devices Market Outlook to 2020 3Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2
... ... Schizophrenia, WASHINGTON, MAY 6 Data ... candidate,iloperidone, included its 4-week, short-term Phase III trial, as well as ... of iloperidone. Iloperidone is a 5HT2/D2 antagonist ("atypical"),antipsychotic currently under review ...
... - Data Presented in Poster Session at American College ... Gynecologists, 56th Annual ... PEAK Surgical, Inc., a medical,device company that is ... released results from a preclinical study,demonstrating that its PEAK ...
Cached Medicine Technology:Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery 2PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery 3PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery 4
(Date:9/17/2014)... US medical facilities are expected to ... in 2014. Due to public safety concerns, such waste ... municipal solid waste. An increasing number of laws and ... This includes disposable items that may be contaminated by ... a result of increased regulation, most small quantity RMW-generating ...
(Date:9/17/2014)... York (PRWEB) September 18, 2014 Mercy College ... Dean of the School of Social and Behavioral Sciences. ... enhancing the quality of the academic mission of the dynamic ... Dean said: “I am honored to join Mercy College. ... staff members across the campuses dedicated to the educational mission ...
(Date:9/17/2014)... September 17, 2014 In its latest ... drug and alcohol treatment program that gets clients off ... foundation in recovery they can believe in, is exploring ... 20% of Americans who are afflicted with depression are ... Forever Recovery’s CEO Per Wickstrom . “Unfortunately, these ...
(Date:9/17/2014)... September 17, 2014 Fitness-conscious people are ... even when they're already practicing or participating in specific ... to design a special fitness system that employs resistance ... or football," said an inventor from Maynard, Mass. , ... SYSTEM, which maximizes a body workout while the user ...
(Date:9/17/2014)... Cut Pro X plugin developers have announced a new anamorphic ... “ProBlue 5k is a compilation of anamorphic flares that can ... Austin, CEO of Pixel Film Studios. “Blurring the line between ... , ProBlue 5k is the ultimate Ultra High Definition anamorphic ... compilation of over 100 anamorphic flares can be applied to ...
Breaking Medicine News(10 mins):Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Mercy College Welcomes New Dean of the School of Social and Behavioral Sciences 2Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 2Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 3Health News:A New Plugin Entitled ProBlue 5k Was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2
... Research Inc. (TSX: NRI), a Canadian drug development company ... that are delivered to and through the skin using ... its financial and operational results for the year and ... Key Corporate Developments:, - ...
... radiologists and referring, ... physicians and specialists , ... GE Healthcare,announced today in Asia the release of Centricity PACS Web ... is tightly,integrated to Centricity RIS/ PACS, which bring comprehensive detailed patient,history ...
... Nursing Productivity in the Treatment of Renal Disease , ... ... 2009 -- iSirona®, an innovative provider of data automation solutions ... agreement with NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer ...
... announces the implementation of its rehabilitation software by HealthPoint ... Southeast Missouri Hospital, a 269-bed regional medical complex serving ... functionality for electronically managing therapy documentation, scheduling, referrals, insurance ... ...
... , New web-based research has quantified the attractiveness of ... the features of one woman into 243 variations with ... waist widths. Then more than 34,000 people judged the ... exactly the same in all of the photos, researchers ...
... Modernizes TechnologyWASHINGTON, Feb. 26 President Obama,s first ... (VA) expands eligibility for health care to an ... years, meets the need for continued growth in ... Afghanistan and provides the resources to deliver quality ...
Cached Medicine News:Health News:Nuvo announces 2008 fourth quarter and year-end financial results 2Health News:Nuvo announces 2008 fourth quarter and year-end financial results 3Health News:Nuvo announces 2008 fourth quarter and year-end financial results 4Health News:Nuvo announces 2008 fourth quarter and year-end financial results 5Health News:Nuvo announces 2008 fourth quarter and year-end financial results 6Health News:Nuvo announces 2008 fourth quarter and year-end financial results 7Health News:Nuvo announces 2008 fourth quarter and year-end financial results 8Health News:Nuvo announces 2008 fourth quarter and year-end financial results 9Health News:Nuvo announces 2008 fourth quarter and year-end financial results 10Health News:Nuvo announces 2008 fourth quarter and year-end financial results 11Health News:Nuvo announces 2008 fourth quarter and year-end financial results 12Health News:GE Healthcare Introduces New Web-Based Diagnostic Viewer with Workflow Integration and Streaming Technology for Hospitals in Asia 2Health News:GE Healthcare Introduces New Web-Based Diagnostic Viewer with Workflow Integration and Streaming Technology for Hospitals in Asia 3Health News:iSirona Signs Reference Selling Agreement with NxStage 2Health News:Southeast Missouri Hospital Implements Chart Links Rehabilitation Software for Therapists 2Health News:Southeast Missouri Hospital Implements Chart Links Rehabilitation Software for Therapists 3Health News:Plastic and reconstructive surgery ... in brief 2Health News:President's 2010 Budget Request Strongly Supports VA Programs 2
Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l...
Convenient clip-activated switch with removable cobalt blue filter attachment....
Convenient clip-activated switch with imprinted 2 mm - 9 mm pupil gauge and medical caduceus....
... most affordable, compact and lightweight video magnifier. ... 18 pounds, the Companion is the perfect ... Companions easy-to-use controls allow you to read ... magazines, newspapers and even curved surfaces on ...
Medicine Products: